Digestive Diseases and Sciences

, Volume 63, Issue 5, pp 1355–1362 | Cite as

Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?

  • Karen V. Danielsen
  • Signe Wiese
  • Jens Hove
  • Flemming Bendtsen
  • Søren Møller
Original Article
  • 52 Downloads

Abstract

Background

The relation between excessive alcohol consumption and coronary arteriosclerosis has remained controversial. The etiology of cirrhosis has been considered a substantial risk factor for development of arteriosclerotic lesions. The coronary artery calcium-score derived from coronary CT angiography is a robust marker of coronary arteriosclerosis.

Aims

To study the burden of coronary arteriosclerosis in cirrhotic patients of various etiologies and association to cardiac dysfunction and survival.

Methods

Fifty-seven patients with cirrhosis without cardiovascular disease underwent coronary CT angiography, tissue Doppler echocardiography, electrocardiogram and registration of clinical and biochemical characteristics.

Results

In patients with cirrhosis the median coronary artery calcium-score was increased in comparison with age and race-adjusted healthy reference values (men: 328 vs. 9 HU and women: 136 vs. 0 HU; p < 0.001). Moreover, the coronary artery calcium-score in alcohol-related cirrhosis was significantly higher than in nonalcohol-related cirrhosis (362 vs. 46 HU, p < 0.001). Coronary artery calcium-score correlated with age (p = 0.002) but not with established cardiovascular risk factors including smoking, type 2 diabetes, hypertension, gender, or hypercholesterolemia. Coronary artery calcium-score was associated with diastolic dysfunction, lateral e´ (p = 0.025), but not with other markers of cardiac dysfunction. During a median follow-up of 25 months 12 patients (21%) died but coronary artery calcium-score was not associated with survival.

Conclusions

Coronary arteriosclerosis was particular extensive in patients with alcoholic cirrhosis. However, the current results suggest that coronary arteriosclerosis only have limited influence on cardiac function and survival. Surprisingly, no other established risk factors apart from age seemed to interfere with coronary arteriosclerosis in cirrhotic patients.

Keywords

Alcoholic cirrhosis Portal hypertension Coronary artery calcium Coronary angiography Cardiomyopathies 

Notes

Acknowledgments

We sincerely thank the staff at Centre for Functional and Diagnostic Imaging and Research, Hvidovre University Hospital for the effort. We thank Allan Poulsen and Hanne Halgreen for their impressive help with the echocardiography measurements and we also thank laboratory technician Katrine Lyngby for her excellent assistance. This project has received financial support and funds from Novo Nordisk Foundation and Amager Hvidovre University Hospital Research Foundation.

Compliance with ethical standards

Conflict of interest

None of the authors had any personal or financial conflicts of interest.

References

  1. 1.
    Andrews J, Puri R, Kataoka Y, Nicholls SJ, Psaltis PJ. Therapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studies. Cardiovasc Diagn Ther. 2016;6:282–303.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    An J, Shim JH, Kim S-O, et al. Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study. Circulation. 2014;130:1353–1362.CrossRefPubMedGoogle Scholar
  3. 3.
    Kianoush S, Al Rifai M, Cainzos-Achirica M, et al. An update on the utility of coronary artery calcium scoring for coronary heart disease and cardiovascular disease risk prediction. Curr Atheroscler Rep. 2016;18:13.CrossRefPubMedGoogle Scholar
  4. 4.
    Voulgaris T, Sevastianos VA. Atherosclerosis as extrahepatic manifestation of chronic infection with hepatitis C virus. Hepat Res Treat. 2016;2016:7629318.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Kokolis S, Marmur JD, Clark LT, et al. Effects of alcoholism on coronary artery disease and left ventricular dysfunction in male veterans. J Invasive Cardiol. 2006;18:304–307.PubMedGoogle Scholar
  6. 6.
    Kalaitzakis E, Björnsson E. Coronary artery disease in liver cirrhosis: does the aetiology of liver disease matter? J Hepatol. 2009;51:962–963.CrossRefPubMedGoogle Scholar
  7. 7.
    Møller S, Wiese S, Halgreen H, Hove JD. Diastolic dysfunction in cirrhosis. Heart Fail Rev. 2016;21:599–610.CrossRefPubMedGoogle Scholar
  8. 8.
    Møller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013;34:2804–2811.CrossRefPubMedGoogle Scholar
  9. 9.
    Bittencourt MS, Hulten E, Ghoshhajra B, et al. Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ Cardiovasc Imaging. 2014;7:282–291.CrossRefPubMedGoogle Scholar
  10. 10.
    Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–832.CrossRefPubMedGoogle Scholar
  11. 11.
    Nakanishi R, Li D, Blaha MJ, et al. The relationship between coronary artery calcium score and the long-term mortality among patients with minimal or absent coronary artery risk factors. Int J Cardiol. 2015;185:275–281.CrossRefPubMedGoogle Scholar
  12. 12.
    Nasir K, Rubin J, Blaha MJ, et al. Interplay of coronary artery calcification and traditional risk factors for the prediction of all-cause mortality in asymptomatic individuals. Circ Cardiovasc Imaging. 2012;5:467–473.CrossRefPubMedGoogle Scholar
  13. 13.
    Agatston AS, Janowitz WR, Kaplan G, Gasso J, Hildner F, Viamonte M. Ultrafast computed tomography-detected coronary calcium reflects the angiographic extent of coronary arterial atherosclerosis. Am J Cardiol. 1994;74:1272–1274.CrossRefPubMedGoogle Scholar
  14. 14.
    Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Hear J Cardiovasc Imaging. 2015;16:233–271.CrossRefGoogle Scholar
  15. 15.
    Pletcher MJ, Sibley CT, Pignone M, Vittinghoff E, Greenland P. Interpretation of the coronary artery calcium score in combination with conventional cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2013;128:1076–1084.CrossRefPubMedGoogle Scholar
  16. 16.
    Kalaitzakis E, Rosengren A, Skommevik T, Björnsson E. Coronary artery disease in patients with liver cirrhosis. Dig Dis Sci. 2010;55:467–475.CrossRefPubMedGoogle Scholar
  17. 17.
    Keeling AN, Flaherty JD, Davarpanah AH, et al. Coronary multidetector computed tomographic angiography to evaluate coronary artery disease in liver transplant candidates: methods, feasibility and initial experience. J Cardiovasc Med. 2011;12:460–468.CrossRefGoogle Scholar
  18. 18.
    Kemmer N, Case J, Chandna S, Neff GW. The role of coronary calcium score in the risk assessment of liver transplant candidates. Transplant Proc. 2014;46:230–233.CrossRefPubMedGoogle Scholar
  19. 19.
    Kawakami M, Koda M, Murawaki Y. The prevalence of atherosclerosis in cirrhotic patients: assessment of two aspects of atherosis and sclerosis. Hepatol Res. 2007;37:152–157.CrossRefPubMedGoogle Scholar
  20. 20.
    Berzigotti A, Bonfiglioli A, Muscari A, et al. Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis. Liver Int. 2005;25:331–336.CrossRefPubMedGoogle Scholar
  21. 21.
    Marchesini G, Ronchi M, Forlani G, et al. Cardiovascular disease in cirrhosis. A point-prevalence study in relation to glucose tolerance. Am J Gastroenterol. 1999;94:655–662.PubMedGoogle Scholar
  22. 22.
    Kazankov K, Munk K, Øvrehus KA, et al. High burden of coronary atherosclerosis in patients with cirrhosis. Eur J Clin Invest. 2017;47:565–573.CrossRefPubMedGoogle Scholar
  23. 23.
    Gologorsky E, Pretto EA, Fukazawa K. Coronary artery disease and its risk factors in patients presenting for liver transplantation. J Clin Anesth.. 2013;25:618–623.CrossRefPubMedGoogle Scholar
  24. 24.
    Kadayifci A, Tan V, Ursell PC, Merriman RB, Bass NM. Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies. J Hepatol. 2008;49:595–599.CrossRefPubMedGoogle Scholar
  25. 25.
    McAvoy NC, Kochar N, McKillop G, Newby DE, Hayes PC. Prevalence of coronary artery calcification in patients undergoing assessment for orthotopic liver transplantation. Liver Transpl. 2008;14:1725–1731.CrossRefPubMedGoogle Scholar
  26. 26.
    Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transplant Surg. 1996;2:426–430.CrossRefGoogle Scholar
  27. 27.
    Tiukinhoy-Laing SD, Rossi JS, Bayram M, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol. 2006;98:178–181.CrossRefPubMedGoogle Scholar
  28. 28.
    Cassagneau P, Jacquier A, Giorgi R, et al. Prognostic value of preoperative coronary computed tomography angiography in patients treated by orthotopic liver transplantation. Eur J Gastroenterol Hepatol. 2012;24:558–562.CrossRefPubMedGoogle Scholar
  29. 29.
    Patel S, Kiefer TL, Ahmed A, et al. Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease. Am J Cardiol. 2011;108:1552–1555.CrossRefPubMedGoogle Scholar
  30. 30.
    Carey WD, Dumot JA, Pimentel RR, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation. 1995;59:859–864.CrossRefPubMedGoogle Scholar
  31. 31.
    Burroughs AK, Sabin CA, Rolles K, et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet. 2006;367:225–232.CrossRefPubMedGoogle Scholar
  32. 32.
    Safadi A, Homsi M, Maskoun W, et al. Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery. Circulation. 2009;120:1189–1194.CrossRefPubMedGoogle Scholar
  33. 33.
    Thomsen JL. Atherosclerosis in alcoholics. Forensic Sci Int. 1995;75:121–131.CrossRefPubMedGoogle Scholar
  34. 34.
    Howell WL, Manion WC. The low incidence of myocardial infarction in patients with portal cirrhosis of the liver: a review of 639 cases of cirrhosis of the liver from 17,731 autopsies. Am Heart J. 1960;60:341–344.CrossRefPubMedGoogle Scholar
  35. 35.
    Malyutina S, Bobak M, Kurilovitch S, et al. Relation between heavy and binge drinking and all-cause and cardiovascular mortality in Novosibirsk, Russia: a prospective cohort study. Lancet. 2002;360:1448–1454.CrossRefPubMedGoogle Scholar
  36. 36.
    Agarwal DP. Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. Alcohol Alcohol. 2002;37:409–415.CrossRefPubMedGoogle Scholar
  37. 37.
    Grønbaek M. The positive and negative health effects of alcohol- and the public health implications. J Intern Med. 2009;265:407–420.CrossRefPubMedGoogle Scholar
  38. 38.
    Cho I-J, Chang H-J, Park H-B, et al. Aortic calcification is associated with arterial stiffening, left ventricular hypertrophy, and diastolic dysfunction in elderly male patients with hypertension. J Hypertens. 2015;33:1633–1641.CrossRefPubMedGoogle Scholar
  39. 39.
    Hickler RB. Aortic and large artery stiffness: current methodology and clinical correlations. Clin Cardiol.. 1990;13:317–322.CrossRefPubMedGoogle Scholar
  40. 40.
    Ruiz-del-Árbol L, Serradilla R. Cirrhotic cardiomyopathy. World J Gastroenterol. 2015;21:11502–11521.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Kiszka-Kanowitz M, Henriksen JH, Møller S, Bendtsen F. Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique. J Hepatol. 2001;35:605–612.CrossRefPubMedGoogle Scholar
  42. 42.
    Wiese S, Hove JD, Bendtsen F, Møller S. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol. 2013;11:177–186.CrossRefPubMedGoogle Scholar
  43. 43.
    Sørensen HT, Thulstrup AM, Mellemkjar L, et al. Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark. J Clin Epidemiol. 2003;56:88–93.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Centre for Functional and Diagnostic Imaging, Department of Clinical Physiology and Nuclear MedicineHvidovre HospitalHvidovreDenmark
  2. 2.Centre for Gastroenterology and Hepatology, Department of medicineHvidovre HospitalHvidovreDenmark
  3. 3.Department of CardiologyHvidovre HospitalCopenhagenDenmark

Personalised recommendations